Your browser doesn't support javascript.
loading
The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine.
Garofalo, Andrea; Sholl, Lynette; Reardon, Brendan; Taylor-Weiner, Amaro; Amin-Mansour, Ali; Miao, Diana; Liu, David; Oliver, Nelly; MacConaill, Laura; Ducar, Matthew; Rojas-Rudilla, Vanesa; Giannakis, Marios; Ghazani, Arezou; Gray, Stacy; Janne, Pasi; Garber, Judy; Joffe, Steve; Lindeman, Neal; Wagle, Nikhil; Garraway, Levi A; Van Allen, Eliezer M.
Afiliação
  • Garofalo A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • Sholl L; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, 02142, USA.
  • Reardon B; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Taylor-Weiner A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • Amin-Mansour A; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, 02142, USA.
  • Miao D; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, 02142, USA.
  • Liu D; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, 02142, USA.
  • Oliver N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • MacConaill L; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, 02142, USA.
  • Ducar M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • Rojas-Rudilla V; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, 02142, USA.
  • Giannakis M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • Ghazani A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • Gray S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Janne P; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Garber J; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.
  • Joffe S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • Lindeman N; Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, MA, 02142, USA.
  • Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • Garraway LA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
  • Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02115, USA.
Genome Med ; 8(1): 79, 2016 07 26.
Article em En | MEDLINE | ID: mdl-27460824

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Regulação Neoplásica da Expressão Gênica / Neoplasias do Colo / Medicina de Precisão / Neoplasias Pulmonares / Antígenos de Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma / Regulação Neoplásica da Expressão Gênica / Neoplasias do Colo / Medicina de Precisão / Neoplasias Pulmonares / Antígenos de Neoplasias Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article